These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8964415)

  • 1. Kupffer cell erythrophagocytosis and graft-versus-host hemolysis in liver transplantation.
    Clavien PA; Camargo CA; Cameron R; Washington MK; Phillips MJ; Greig PD; Levy GA
    Gastroenterology; 1996 Jun; 110(6):1891-6. PubMed ID: 8964415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of elimination of donor Kupffer cells and/or recipient macrophages on acute rejection in liver transplantation.
    Akamatsu Y; Ohkohchi N; Doi H; Satomi S
    Hepatogastroenterology; 2003; 50(52):1105-10. PubMed ID: 12845991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron microscopy of Kupffer cells in the orthotopic porcine liver homograft during the late stage after transplantation (phagocytosis of host cells by Kupffer cells).
    Cossel L
    Exp Pathol (Jena); 1975; 11(3-4):168-81. PubMed ID: 786714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.
    Miyagawa-Hayashino A; Tsuruyama T; Egawa H; Haga H; Sakashita H; Okuno T; Toyokuni S; Tamaki K; Yamabe H; Manabe T; Uemoto S
    Am J Pathol; 2007 Nov; 171(5):1499-508. PubMed ID: 17823283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Liver Biopsies in Liver Transplant Recipients.
    Voigtländer T; Alten TA; Kirstein MM; Lehner F; Manns MP; Schlué J; Wedemeyer H; Lankisch TO
    Ann Transplant; 2017 Feb; 22():108-114. PubMed ID: 28232660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phagocytosis of lymphocytes in the orthopic porcine liver homograft (author's transl)].
    Cossel L
    Zentralbl Allg Pathol; 1977; 121(4-5):481-8. PubMed ID: 335713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Kupffer cells in liver transplantation.
    Huang HF; Zeng Z; Chen MQ
    Hepatogastroenterology; 2012 Jun; 59(116):1251-7. PubMed ID: 22440189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological long-term outcomes from acute antibody-mediated rejection following ABO-compatible liver transplantation.
    Del Bello A; Danjoux M; Congy-Jolivet N; Lavayssière L; Esposito L; Muscari F; Kamar N
    J Gastroenterol Hepatol; 2017 Apr; 32(4):887-893. PubMed ID: 27739606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multiple Facets of Iron Recycling.
    Slusarczyk P; Mleczko-Sanecka K
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.
    Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Kitahara M; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Onishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
    Transplant Proc; 2014 Dec; 46(10):3523-35. PubMed ID: 25498084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients.
    Dao M; Habès D; Taupin JL; Mussini C; Redon MJ; Suberbielle C; Jacquemin E; Gonzales E; Guettier C
    Liver Transpl; 2018 Jul; 24(7):897-907. PubMed ID: 29704327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bile acids in liver transplantation--early indicator for acute rejection and monitor for antirejection therapy.
    Janssen H; Lange R; Erhard J; Testa G; Malagó M; Janssen P; Eigler FW; Broelsch CE
    Transpl Int; 2001 Dec; 14(6):429-37. PubMed ID: 11793041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined liver-total bowel transplantation has no immunologic advantage over total bowel transplantation alone. A prospective study in a porcine model.
    Gruessner RW; Nakhleh RE; Benedetti E; Pirenne J; Belani KG; Beebe D; Carr R; Troppmann C; Gruessner AC
    Arch Surg; 1997 Oct; 132(10):1077-85. PubMed ID: 9336505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation. Its role in the diagnosis of acute rejection.
    Umeshita K; Monden M; Tono T; Hasuike Y; Kanai T; Gotoh M; Mori T; Shaked A; Busuttil RW
    Ann Surg; 1996 Feb; 223(2):204-11. PubMed ID: 8597516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of graft-resident Kupffer cells and lymphocytes of donor type during the time course after liver transplantation--a clinico-pathological study.
    Bittmann I; Bottino A; Baretton GB; Gerbes AL; Zachoval R; Rau HG; Löhrs U
    Virchows Arch; 2003 Oct; 443(4):541-8. PubMed ID: 12884038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine improves graft survival after experimental liver transplantation.
    Schemmer P; Liang R; Kincius M; Flechtenmacher C; Bunzendahl H; Gutt CN; Mehrabi A; Gebhard MM; Büchler MW; Kraus TW
    Liver Transpl; 2005 Aug; 11(8):950-9. PubMed ID: 16035074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined liver damage from primary biliary cirrhosis, primary sclerosing cholangitis, liver allograft rejection and graft-versus-host disease].
    Kogan J; Ilan I
    Harefuah; 2000 Jan; 138(1):38-41. PubMed ID: 10868178
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Carolina rinse solution on Kupffer cell activation after reperfusion in rat liver transplantation.
    Post S; Rentsch M; Palma P; Gonzalez AP; Otto G; Menger MD
    Transplant Proc; 1992 Dec; 24(6):2703. PubMed ID: 1465906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.